Clinical Trial Update: Phase III Study of Chondrocyte Alginate Gel Suspension in Pediatric Patients With Vesicoureteral Reflux [Phase 3]

View source ↗

Summary

Phase III study of a chondrocyte alginate gel suspension for vesicoureteral reflux in pediatric patients; the current trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vesicoureteral Reflux

Drugs mentioned

• Chondrocyte Alginate Gel Suspension

Snippet

Sponsor: FDA Office of Orphan Products Development | Conditions: Vesicoureteral Reflux | Phase 3 | Status: UNKNOWN